Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NeoMaterna
- Development stage
- Unknown
- Lead developer
- Trifluent Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
NeoMaterna is a prenatal multivitamin and mineral supplement developed and marketed by Trifluent Pharma. As a generic version of established prenatal formulations, it is designed to meet the increased nutritional demands of women during pregnancy and the postpartum period. The product typically contains a comprehensive blend of essential nutrients, including folic acid (to reduce the risk of neural tube defects), iron (to support increased red blood cell production), calcium (for fetal bone development), and a variety of vitamins (A, C, D, E, and B-complex) that serve as vital cofactors in maternal and fetal metabolism. NeoMaterna is provided in an oral tablet form and is categorized as both a pharmaceutical product (often requiring a prescription for high-potency versions) and a nutraceutical supplement.
- Brand names
- NeoMaterna
- Other names
- NeoMaterna Prenatal Multivitamin/Mineral Tablet
02
Targets
TFRC (Transferrin Receptor)CaSR (Extracellular calcium-sensing receptor)FOLR1 (FRα)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on NeoMaterna.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeoMaterna.